185750.KS
Chong Kun Dang Pharmaceutical Corp.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 68,200.00
−1.59%Margins
Gross margin
29.0%
EBITDA margin
7.0%
EBIT margin
4.3%
Net margin
4.5%
FCF margin
-3.9%
7.8%
Return on equity
4.3%
Return on assets
5.3%
Return on invested capital
0.96x
Asset turnover
KRW 123.3B
Cash from operations
KRW 23.9K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026